Please wait while we load the requested 10-Q report or click the link below:
https://last10k.com/sec-filings/report/1622996/000164033417001056/acbm_10q.htm
Document And Entity Information - shares | 6 Months Ended | |
---|---|---|
Mar. 31, 2017 | May 18, 2017 | |
Document And Entity Information [Abstract] | ||
Entity Registrant Name | ACRO BIOMEDICAL CO., LTD. | |
Entity Central Index Key | 0001622996 | |
Trading Symbol | acbm | |
Current Fiscal Year End Date | --09-30 | |
Entity Filer Category | Smaller Reporting Company | |
Entity Common Stock, Shares Outstanding | 47,160,000 | |
Document Type | 10-Q | |
Document Period End Date | Mar. 31, 2017 | |
Amendment Flag | false | |
Document Fiscal Year Focus | 2017 | |
Document Fiscal Period Focus | Q2 |
Please wait while we load the requested 10-Q report or click the link below:
https://last10k.com/sec-filings/report/1622996/000164033417001056/acbm_10q.htm
Compare this 10-Q Quarterly Report to its predecessor by reading our highlights to see what text and tables were removed , added and changed by Acro Biomedical Co., Ltd..
Acro Biomedical Co., Ltd.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2017 10-K Annual Report includes:
Financial Statements, Disclosures and Schedules
Inside this 10-Q Quarterly Report
Material Contracts, Statements, Certifications & more
Acro Biomedical Co., Ltd. provided additional information to their SEC Filing as exhibits
Ticker: ACBM
CIK: 1622996
Form Type: 10-Q Quarterly Report
Accession Number: 0001640334-17-001056
Submitted to the SEC: Mon May 22 2017 1:01:32 PM EST
Accepted by the SEC: Mon May 22 2017
Period: Friday, March 31, 2017
Industry: Amusement And Recreation Services